Updated Asthma Management Guidelines According to GINA 2026
Modern asthma management is based on continuous assessment, treatment adjustment according to response, and review of risk factors and comorbidities to achieve optimal symptom control.
In adults, adolescents and children aged 6 to 11 years, the guidelines recommend using treatment regimens that contain ICS-formoterol in the early stages, with possible escalation to ICS-LABA regimens such as Budevent, including the option to increase the dose of the combination in later steps, or to add Sprivavent when additional support from the LAMA class is needed.
Proper inhaler technique, adherence, and a clear follow-up plan remain essential to treatment success.
To access the full details of the guideline, you can visit the GINA website via the following link: